HYALGAN Solution for injection Ref.[7901] Active ingredients: Hyaluronate sodium

Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Multi-pharm Co Ltd, 24, Apollonos Str., 1046, Nicosia, Cyprus

Product name and form

HYALGAN 20mg/2ml solution for intra-articular injection.

Pharmaceutical Form
Solution for intra-articular injection.

Qualitative and quantitative composition

Active ingredient: Hyaluronic acid sodium salt 20 mg.

See point 6.1 for details of excipients.

Active Ingredient	Description
Hyaluronate sodium

List of Excipients
Sodium chloride Sodium dihydrogen phosphate dihydrate Disodium hydrogen phosphate dodecahydrate Water for injections

Pack sizes and marketing

Colourless glass vial with elastomer stopper and aluminium flip-off seal.

1 vial of 20 mg/2 ml

Marketing authorization holder

Multi-pharm Co Ltd, 24, Apollonos Str., 1046, Nicosia, Cyprus

Marketing authorization dates and numbers

19609

Date of first authorisation: 30/04/2004
Date of renewal of authorisation: 10/09/2010

Drugs

Drug	Countries
HYALGAN	Austria, Cyprus, Ecuador, Spain, France, Hong Kong, Lithuania, Poland, Romania, Singapore, Tunisia

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.